Mouse sEV infusion experiments showed that PD-L1 blockade on sEVs attenuated their tumor growth-promoting effect and inhibition of CD8+ TILs by sEVWT and sEVS345D (Fig. 5c, d; Supplementary Fig. 12e). Here, CD8A is linked to neoplasm.